» Articles » PMID: 34615928

Cytosolic Protein Delivery Using PH-responsive, Charge-reversible Lipid Nanoparticles

Overview
Journal Sci Rep
Specialty Science
Date 2021 Oct 7
PMID 34615928
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Although proteins have attractive features as biopharmaceuticals, the difficulty in delivering them into the cell interior limits their applicability. Lipid nanoparticles (LNPs) are a promising class of delivery vehicles. When designing a protein delivery system based on LNPs, the major challenges include: (i) formulation of LNPs with defined particle sizes and dispersity, (ii) efficient encapsulation of cargo proteins into LNPs, and (iii) effective cellular uptake and endosomal release into the cytosol. Dioleoylglycerophosphate-diethylenediamine (DOP-DEDA) is a pH-responsive, charge-reversible lipid. The aim of this study was to evaluate the applicability of DOP-DEDA-based LNPs for intracellular protein delivery. Considering the importance of electrostatic interactions in protein encapsulation into LNPs, a negatively charged green fluorescent protein (GFP) analog was successfully encapsulated into DOP-DEDA-based LNPs to yield diameters and polydispersity index of < 200 nm and < 0.2, respectively. Moreover, ~ 80% of the cargo proteins was encapsulated into the LNPs. Cytosolic distribution of fluorescent signals of the protein was observed for up to ~ 90% cells treated with the LNPs, indicating the facilitated endocytic uptake and endosomal escape of the cargo attained using the LNP system.

Citing Articles

Targeted protein delivery based on stimuli-triggered nanomedicine.

Liu J, Zhou Y, Lyu Q, Yao X, Wang W Exploration (Beijing). 2024; 4(3):20230025.

PMID: 38939867 PMC: 11189579. DOI: 10.1002/EXP.20230025.


Antibody-Loading of Biological Nanocarrier Vesicles Derived from Red-Blood-Cell Membranes.

Sanaee M, Ronquist K, Sandberg E, Morrell J, Widengren J, Gallo K ACS Omega. 2024; 9(21):22711-22718.

PMID: 38826552 PMC: 11137724. DOI: 10.1021/acsomega.4c00650.


A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation.

Burgess S, Paul N, Richards M, Ault J, Askenatzis L, Claydon S Open Biol. 2024; 14(3):230376.

PMID: 38503329 PMC: 10960945. DOI: 10.1098/rsob.230376.


Layer-by-Layer siRNA Particle Assemblies for Localized Delivery of siRNA to Epithelial Cells through Surface-Mediated Particle Uptake.

Lee A, Gosnell N, Milinkovic D, Taladriz-Blanco P, Rothen-Rutishauser B, Petri-Fink A ACS Appl Bio Mater. 2023; 6(1):83-92.

PMID: 36598879 PMC: 9847476. DOI: 10.1021/acsabm.2c00668.


Polymeric Nanostructures Containing Proteins and Peptides for Pharmaceutical Applications.

Vardaxi A, Kafetzi M, Pispas S Polymers (Basel). 2022; 14(4).

PMID: 35215689 PMC: 8877994. DOI: 10.3390/polym14040777.

References
1.
Akita H, Kogure K, Moriguchi R, Nakamura Y, Higashi T, Nakamura T . Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J Control Release. 2010; 143(3):311-7. DOI: 10.1016/j.jconrel.2010.01.012. View

2.
Kaushik S, Cuervo A . Proteostasis and aging. Nat Med. 2015; 21(12):1406-15. DOI: 10.1038/nm.4001. View

3.
van Meer G, Voelker D, Feigenson G . Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008; 9(2):112-24. PMC: 2642958. DOI: 10.1038/nrm2330. View

4.
Yonezawa S, Koide H, Asai T . Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Adv Drug Deliv Rev. 2020; 154-155:64-78. PMC: 7406478. DOI: 10.1016/j.addr.2020.07.022. View

5.
Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U . Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol. 2013; 31(7):638-46. DOI: 10.1038/nbt.2612. View